United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded May 21, 2026 · Filed May 21, 2026

On May 21, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$562.82 for US$4.67M under a trading plan, leaving 45,172 shares. Filed May 21, 2026 (Form 4).

Sold
8,300 shares
Price
US$562.82 average (US$555.72 to US$566.05)
Value
US$4.67M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockOption exercise300US$146.0345,472Direct
May 21, 2026Common StockOption exercise8,000US$146.0353,472Direct
May 21, 2026Common StockSale110US$555.7253,362Direct
May 21, 2026Common StockSale10US$556.7053,352Direct
May 21, 2026Common StockSale640US$557.8552,712Direct
May 21, 2026Common StockSale200US$559.9952,512Direct
May 21, 2026Common StockSale2,178US$561.9950,334Direct
May 21, 2026Common StockSale1,326US$562.9349,008Direct
May 21, 2026Common StockSale2,015US$564.0646,993Direct
May 21, 2026Common StockSale1,251US$565.2045,742Direct
May 21, 2026Common StockSale270US$566.0545,472Direct
May 21, 2026Common StockSale300US$562.5045,172Direct

Source

View original at SEC

Related